An organosulfonic acid containing one or more amino groups.
ChEBI ID: 37793
| Member | Definition | Role |
|---|---|---|
| bes | A Good's buffer substance, pKa = 7.15 at 20 degreeC. | 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid; 2-[bis(2-hydroxyethyl)ammonio]ethanesulfonate |
| cysteic acid | An amino sulfonic acid that is the sulfonic acid analogue of cysteine. | cysteic acid |
| dipyrone | A pyrazole that is antiipyrine substituted at C-4 by a methyl(sulfomethyl)amino group, the sodium salt of which, metamizole sodium, was widely used as a powerful analgesic and antipyretic, but withdrawn from many markets from the 1970s due to a risk of causing risk of causing agranulocytosis. | metamizole |
| n-(2-acetamido)-2-aminoethanesulfonic acid | A Good's buffer substance, pKa = 6.9 at 20 degreeC. | 2-[(2-amino-2-oxoethyl)ammonio]ethanesulfonate; N-(2-acetamido)-2-aminoethanesulfonic acid |
| taurine | An amino sulfonic acid that is the 2-amino derivative of ethanesulfonic acid. It is a naturally occurring amino acid derived from methionine and cysteine metabolism. An abundant component of fish- and meat-based foods, it has been used as an oral supplement in the treatment of disorders such as cystic fibrosis and hypertension. | taurine zwitterion; taurine |
| taurocholic acid | A bile acid taurine conjugate of cholic acid that usually occurs as the sodium salt of bile in mammals. | taurocholic acid |
| tes | A Good's buffer substance, pKa = 7.5 at 20 degreeC. | N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid; N-tris(hydroxymethyl)methyl-2-ammonioethanesulfonate |
| tramiprosate | An amino sulfonic acid that is the 3-amino derivative of propanesulfonic acid. | 3-aminopropanesulfonic acid zwitterion; 3-aminopropanesulfonic acid |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4,385 (32.29) | 18.7374 |
| 1990's | 2,876 (21.18) | 18.2507 |
| 2000's | 2,792 (20.56) | 29.6817 |
| 2010's | 2,679 (19.73) | 24.3611 |
| 2020's | 849 (6.25) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 476 (3.25%) | 5.53% |
| Reviews | 849 (5.79%) | 6.00% |
| Case Studies | 88 (0.60%) | 4.05% |
| Observational | 18 (0.12%) | 0.25% |
| Other | 13,237 (90.24%) | 84.16% |